Home > Active Biospecimen Request

ACTIVE BIOSPECIMEN REQUESTS

Request Number

Disease

Total subjects

Sample type

Details of request

ID1480

Myelodysplastic Syndrome (MDS)
100

Fresh whole blood or fresh bone marrow

ID1479

Acute Myeloid Leukemia (AML)
100

Fresh whole blood or fresh bone marrow

ID1469

Gastrointestinal Stromal Tumor (GIST)
20

FFPE or Frozen Tissue

ID1445

Subjects with increased CA15-3 concentrations
45

Matched plasma and serum

ID1440

Pediatric Acute Myeloid Leukemia (AML)
20

Viably frozen bone marrow aspirates (preferred) or other sample types

ID1433

Metastatic Gastric Cancer HER2+
10

Plasma

ID1432

Metastatic Breast Cancer HER2+
10

Plasma

ID1428

Pituitary Cancer
10

FFPE and Frozen Tissue

ID1424

Myelofibrosis
5

BMMC or PBMC - Frozen

ID1423

Myelodysplastic Syndrome (MDS)
5

BMMC or PBMC - Frozen

ID1420

Acute Myeloid Leukemia (AML)
5

BMMC or PBMC - Frozen

ID1417

Castration-resistant prostate cancer (CRPC), resistant to Abiraterone
3 - 5

FFPE Blocks/Slides with Matching Plasma

ID1415

Non-small cell lung cancer (NSCLC), resistant to erlotinib or gefitinib
UP TO 20

FFPE Blocks or Slides

ID1407

Acute Myeloid Leukemia (AML)
60

Serum

ID1403

Colorectal Cancer (CRC) and Colorectal Adenoma (CRA)
UP TO 100

Frozen Tissue and/or Frozen Plasma

ID1392

Adrenocortical Carcinoma (ACC)
5

Fresh Tissue

ID1379

Hepatocellular Carcinoma (HCC)
50

Serum and/or Plasma

ID1378

Renal Cancer
30

Serum and/or Plasma

ID1367

Acute Leukemia, Chronic Leukemia or Lymphoma
100

Bone Marrow; Whole Blood

ID1354

Myelodysplastic Syndrome (MDS)
20

BMMC

ID1341

Bladder Cancer
30

FFPE and FROZEN TISSUE

ID1340

Gastric Cancer
30

FFPE and FROZEN TISSUE

ID1339

Prostate Cancer
30

FFPE and FROZEN TISSUE

ID1326

Acute Myeloid Leukemia (AML)
3

BMMC OR PBMC

ID1323

Diffuse Large B Cell Lymphoma
40 plus 10 Healthy Controls

FFPE and Matched Plasma

ID1219

Renal Cell Carcinoma Patients on Anti-PD1 Therapy
Up to 100

FFPE

ID1218

Melanoma Patients on Anti-PD1 Therapy
Up to 100

FFPE

ID1185

Ovarian Cancer with Microsatellite instability (MSI)
20

FFPE